pancreatic carcinoma cells (ATCC)
99
Structured Review
ATCC
pancreatic carcinoma cells
Pancreatic Carcinoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 4501 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mia+paca+2/MIA+PaCa-2/us12655131-711-5-8
Average 99 stars, based on 4501 article reviews
Pancreatic Carcinoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 4501 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mia+paca+2/MIA+PaCa-2/us12655131-711-5-8
Average 99 stars, based on 4501 article reviews
pancreatic carcinoma cells - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
other:Article Title: The Vitamin D3 Analog Calcipotriol Attenuates Pancreatic Cancer Malignancy via Downregulating Thrombospondin 1 in Pancreatic Stellate Cells Article Snippet: Human PDAC cell lines PANC‐1 (male, American Type Culture Collection [ Multiple Displacement Amplification:Article Title: MEK interactions tune RAF kinase sensitivity to conformation-selective inhibition. Article Snippet: .. All cancer cell lines used in this study, namely Cell Culture:Article Title: MEK interactions tune RAF kinase sensitivity to conformation-selective inhibition. Article Snippet: .. All cancer cell lines used in this study, namely Article Title: RBM15-Mediated m6A Modification Regulates Proliferation and Migration of Pancreatic Cancer Cells via the lncRNA LINC01320/miR-1287-5p/FBXO11 Axis Article Snippet: .. PC cell lines Panc 03.27 (CRL-2549; RRID:CVCL_1635), SW1990 (CRL-2172; RRID:CVCL_1723), BxPc3 (CRL-1687; RRID:CVCL_XX78), and Article Title: Fra-2 controls the response to the KRAS inhibitor MRTX-1133 in pancreatic ductal adenocarcinoma. Article Snippet: KRAS mutations are present in the majority of pancreatic ductal adenocarcinomas (PDAC) and are key drivers of tumor progression.. Although mutation-specific KRAS inhibitors (KRASi) have shown encouraging clinical activity, their therapeutic benefit is limited by the insurgence of resistance.. Here, we hypothesized that the stress-response mediator Fra-2 contributes to this resistance. Modification:Article Title: METTL3-driven m 6 A modification promotes tumor progression and immune evasion in hypoxic pancreatic cancer by enhancing ADAM10-mediated MICA shedding. Article Snippet: .. Cell lines and cultivation Human pancreatic cancer cell lines PANC-1 (CRL-1469) and |